Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

127 record(s) found.

Entheogen: psilocybin
Study Title: Psilocybin-assisted CBT for Depression
Start Date: Jan 01, 2023 - Last Update: July 25, 2022
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Repeated Psilocybin Dosing in OCD
Start Date: Nov 01, 2022 - Last Update: June 9, 2022
Conditions: Obsessive-Compulsive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Therapy in Advanced Cancer
Start Date: Nov 01, 2022 - Last Update: June 1, 2022
Conditions: Advanced Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted Psychotherapy for Treatment of Alcohol Use Disorder
Start Date: Nov 01, 2022 - Last Update: July 21, 2022
Conditions: Alcohol Use Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pragmatic Trial of Psilocybin Therapy in Palliative Care
Start Date: Oct 01, 2022 - Last Update: June 3, 2022
Conditions: Demoralization
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Start Date: Oct 01, 2022 - Last Update: June 13, 2022
Conditions: Alcohol Use Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Bioavailability Study of Psilocybin in Normal Adults
Start Date: Oct 01, 2022 - Last Update: July 20, 2022
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
Start Date: Oct 01, 2022 - Last Update: July 29, 2022
Conditions: Perception Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
Start Date: Sep 15, 2022 - Last Update: June 30, 2022
Conditions: Anxiety and Depression
Location(s): Jamaica
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
Start Date: Sep 01, 2022 - Last Update: July 29, 2022
Conditions: Treatment Resistant Disorders, Post Traumatic Stress Disorder
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Start Date: Sep 01, 2022 - Last Update: July 19, 2022
Conditions: Methamphetamine Use Disorder, Substance-Related Disorders, Chemically-Induced Disorders, Substance Use Disorders, Stimulant-Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Palliadelic Treatment to Reduce Psychological Distress in Persons With Inoperable Pancreatobiliary Cancer
Start Date: Sep 01, 2022 - Last Update: June 22, 2022
Conditions: Pancreas Cancer, Biliary Tract Cancer, Psychological Distress
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
Start Date: Sep 01, 2022 - Last Update: June 1, 2022
Conditions: Borderline Personality Disorder, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study
Start Date: Sep 01, 2022 - Last Update: May 20, 2022
Conditions: Healthy
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
Start Date: Aug 01, 2022 - Last Update: August 1, 2022
Conditions: Anorexia Nervosa
Location(s): United States, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-facilitated Treatment for Chronic Pain
Start Date: Aug 01, 2022 - Last Update: May 13, 2022
Conditions: Fibromyalgia, Primary
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Exploratory Study of Low Dose Psilocybin
Start Date: Aug 01, 2022 - Last Update: May 13, 2022
Conditions: Demoralization
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Start Date: Aug 01, 2022 - Last Update: July 11, 2022
Conditions: Tobacco Use Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
Start Date: Jul 07, 2022 - Last Update: July 14, 2022
Conditions: Amphetamine-Related Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A Study of a Psilocybin Analog (CYB003) in Participants With Major Depressive Disorder
Start Date: Jul 06, 2022 - Last Update: July 13, 2022
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Start Date: Jul 01, 2022 - Last Update: July 21, 2022
Conditions: Post Traumatic Stress Disorder
Location(s): United States, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional Distress
Start Date: Jul 01, 2022 - Last Update: April 25, 2022
Conditions: Cancer-related Problem/Condition, Depressive Symptoms, Anxiety Disorders
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: ELE-101 Safety & Tolerability Study in Healthy Participants
Start Date: Jul 01, 2022 - Last Update: July 15, 2022
Conditions: Healthy Volunteers
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Post-Treatment Lyme Disease
Start Date: Jul 01, 2022 - Last Update: July 12, 2022
Conditions: Post-Treatment Lyme Disease, Chronic Lyme Disease, Lyme Disease, Chronic
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use
Start Date: Jul 01, 2022 - Last Update: June 30, 2022
Conditions: Opioid Use Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Start Date: Jul 01, 2022 - Last Update: June 2, 2022
Conditions: Alcohol Use Disorder (AUD)
Location(s): Denmark
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: An Evaluation of Psilocybin's Effect on Cardiac Repolarization
Start Date: Jun 22, 2022 - Last Update: July 28, 2022
Conditions: QTc Interval
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Therapy for Chronic Low Back Pain
Start Date: Jun 01, 2022 - Last Update: May 4, 2022
Conditions: Chronic Low-back Pain
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
Start Date: Jun 01, 2022 - Last Update: May 19, 2022
Conditions: Treatment-Resistant Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
Start Date: May 26, 2022 - Last Update: June 8, 2022
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Northwest Therapies Trauma Psilocybin Study Compassionate Use Study
Start Date: May 03, 2022 - Last Update: March 11, 2022
Conditions: Trauma, Nervous System
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Mood and Cognitive Effects of Psilocybin in Healthy Participants
Start Date: Apr 01, 2022 - Last Update: February 23, 2022
Conditions: Mood Disturbance, Mood Change, Sleep Disturbance, Drug Effect, Psychedelic Experiences, Health, Subjective, Psilocin Toxicity, Psilocybin Toxicity, Psilocybin Causing Adverse Effects in Therapeutic Use, Anxiety
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Microdosing Psychedelics to Improve Mood
Start Date: Apr 01, 2022 - Last Update: March 29, 2022
Conditions: Persistent Depressive Disorder, Dysthymia
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Personality and Drug Use (PDU)
Start Date: Apr 01, 2022 - Last Update: April 29, 2022
Conditions: Personality
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder
Start Date: Mar 16, 2022 - Last Update: May 4, 2022
Conditions: Binge Eating Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Start Date: Mar 09, 2022 - Last Update: May 24, 2022
Conditions: Hospice, Psilocybin, Demoralization, Terminal Illness, Cancer-related Problem/Condition, Psychotherapy, Terminal Cancer, Cancer Terminal
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Start Date: Mar 03, 2022 - Last Update: March 29, 2022
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Frontline Clinician Psilocybin Study
Start Date: Mar 03, 2022 - Last Update: July 15, 2022
Conditions: Burnout, Caregiver, Burnout, Professional, COVID-19, Depression, Post Traumatic Stress Disorder, Moral Injury
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Safety and tolerability of psilocybin-assisted physiotherapy in healthy volunteers
Start Date: Mar 01, 2022
Conditions: Functional neurological disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Open-label Study to Assess the Safety and Efficacy of TRP-8802 With Psychotherapy in Adult Participants With Fibromyalgia
Start Date: Mar 01, 2022 - Last Update: November 19, 2021
Conditions: Fibromyalgia
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Psychological and Existential Distress in Palliative Care
Start Date: Mar 01, 2022 - Last Update: November 18, 2021
Conditions: Depression, Anxiety, Distress, Emotional
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
Start Date: Mar 01, 2022 - Last Update: January 3, 2022
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted therapy for refractory Functional Neurological Disorder
Start Date: Mar 01, 2022
Conditions: Functional neurological disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted Therapy for Phantom Limb Pain
Start Date: Mar 01, 2022 - Last Update: February 4, 2022
Conditions: Phantom Limb Pain
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A study to investigate the effects of repeated low doses of psilocybin and ketamine on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action
Start Date: Feb 22, 2022
Conditions: Parkinson's disease
Location(s): Netherlands
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Start Date: Feb 04, 2022 - Last Update: February 8, 2022
Conditions: Treatment Resistant Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Therapy for Depression in Bipolar II Disorder
Start Date: Jan 28, 2022 - Last Update: February 1, 2022
Conditions: Bipolar II Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD
Start Date: Dec 01, 2021 - Last Update: May 12, 2021
Conditions: Obsessive-compulsive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Treatment-Resistant Depression
Start Date: Nov 19, 2021 - Last Update: March 3, 2022
Conditions: Treatment Resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer, a randomized double-blind study with the possibility of entering open extension.
Start Date: Sep 22, 2021
Conditions: Depressive disorder comorbid with cancer
Location(s): Czech Republic
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Visual Surround Suppression and Perceptual Expectation Under Psilocybin
Start Date: Aug 30, 2021 - Last Update: February 17, 2022
Conditions: Perception Disturbance, Visual Suppression, Psychedelic Experiences
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
Start Date: Aug 26, 2021 - Last Update: January 27, 2022
Conditions: Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Start Date: Aug 15, 2021 - Last Update: September 5, 2021
Conditions: Parkinson Disease, Depression, Anxiety
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Start Date: Aug 11, 2021 - Last Update: April 11, 2022
Conditions: Short Lasting Unilateral Neuralgiform Headache Attacks
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
Start Date: Aug 11, 2021 - Last Update: August 18, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Repeat Dosing of Psilocybin in Migraine Headache
Start Date: Aug 10, 2021 - Last Update: October 25, 2021
Conditions: Migraine Headache
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Start Date: Jun 10, 2021 - Last Update: July 29, 2021
Conditions: Treatment-resistant Depression
Location(s): Germany
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Precision Functional Brain Mapping in Psilocybin
Start Date: Jun 01, 2021 - Last Update: June 21, 2022
Conditions: Psilocybin
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Start Date: May 28, 2021 - Last Update: August 25, 2021
Conditions: Anorexia Nervosa
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pilot RECAP Study in Healthy Volunteers
Start Date: May 21, 2021 - Last Update: August 2, 2022
Conditions: Psychedelic Experiences, Amnesia
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
Start Date: May 01, 2021 - Last Update: July 25, 2022
Conditions: Anorexia Nervosa
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Versus Ketamine in Treatment-Resistant Depression
Start Date: May 01, 2021 - Last Update: May 20, 2022
Conditions: Treatment Resistant Depression
Location(s): Czechia
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Start Date: Apr 14, 2021 - Last Update: April 15, 2022
Conditions: Major Depressive Disorder, Alcohol Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Start Date: Mar 24, 2021 - Last Update: March 24, 2022
Conditions: Depressive Symptoms, Depression, Alzheimer Disease, Mild Cognitive Impairment
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Start Date: Mar 01, 2021 - Last Update: November 1, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Start Date: Mar 01, 2021 - Last Update: December 21, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
Start Date: Feb 26, 2021 - Last Update: August 2, 2022
Conditions: Body Dysmorphic Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
Start Date: Feb 18, 2021 - Last Update: January 31, 2022
Conditions: Alcohol Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Naturalistic Study of Microdosing With Psilocybin
Start Date: Jan 20, 2021 - Last Update: December 16, 2021
Conditions: Cognitive Change, Creativity, Mood Change, Sleep
Location(s): Argentina
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Adjunctive Effects of Psilocybin and Buprenorphine
Start Date: Jan 13, 2021 - Last Update: June 3, 2022
Conditions: Opioid Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Start Date: Jan 01, 2021 - Last Update: April 5, 2022
Conditions: Major Depressive Disorder, Depression
Location(s): Sweden
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial.
Start Date: Dec 16, 2020
Conditions: Alcohol Use Disorder
Location(s): Denmark
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
Start Date: Sep 15, 2020 - Last Update: January 26, 2022
Conditions: Treatment Resistant Depression
Location(s): United States, Ireland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Start Date: Sep 01, 2020 - Last Update: October 15, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin in Depression Resistant to Standard Treatments
Start Date: Sep 01, 2020 - Last Update: July 22, 2021
Conditions: Treatment Resistant Depression
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A randomised, placebo controlled trial of psilocybin in treatment resistant depression: A feasibility study
Start Date: Aug 27, 2020
Conditions: Major depressive disorder
Location(s): United Kingdom(United Kingdom, -, no, longer, in, EU/EstoniaA)
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Start Date: Jul 20, 2020 - Last Update: March 3, 2021
Conditions: Treatment Resistant Depression
Location(s): United States, Czechia, Ireland, Netherlands, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin versus ketamine – fast acting antidepressant strategies in treatment-resistant depression
Start Date: Jul 14, 2020
Conditions: The study will include 60 patients with pharmaco-resistant depression (30 male, 30 female, aged 18–65). The basic inclusion criterion is the diagnosis of pharmaco-resistant moderate to severe depre...
Location(s): Czech Republic
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)
Start Date: Jul 08, 2020
Conditions: Treatment-Resistant Depression (P-TRD)
Location(s): Portugal, Czech Republic, Denmark, Netherlands, Germany
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Characterization of Altered Waking States of Consciousness in Healthy Humans
Start Date: Jul 08, 2020 - Last Update: April 29, 2021
Conditions: Altered Waking States of Consciousness in Healthy Humans
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Start Date: Jun 30, 2020 - Last Update: September 30, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
Start Date: Jun 08, 2020 - Last Update: May 20, 2022
Conditions: Alcohol Use Disorder
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Comparative Acute Effects of LSD, Psilocybin and Mescaline
Start Date: May 19, 2020 - Last Update: March 31, 2022
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Prophylactic Effects of Psilocybin on Chronic Cluster Headache
Start Date: Jan 21, 2020 - Last Update: February 21, 2020
Conditions: Cluster Headache
Location(s): Denmark
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effect of 3, 4-Methylenedioxymethamphetamine (MDMA)-assisted therapy on Mood and Anxiety symptoms in advanced-stage Cancer Study
Start Date: Jan 06, 2020
Conditions: Depression symptoms, Anxiety symptoms, Advanced-stage cancer
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: The Canadian Underage Substance Use Prevention Trial
Start Date: Dec 01, 2019 - Last Update: December 17, 2019
Conditions: Substance Use Disorders, Adolescent Behavior, Adolescent Development
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A Study of Psilocybin for Major Depressive Disorder (MDD)
Start Date: Oct 15, 2019 - Last Update: July 19, 2022
Conditions: Depressive Disorder, Major
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted psychotherapy for the treatment of depression and anxiety associated with life-threatening illness
Start Date: Sep 27, 2019
Conditions: Depression in terminal illness (any palliative condition including malignant and non-malignant terminal illnesses), Anxiety in terminal illness (any palliative condition including malignant and non-malignan terminal illnesses)
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Anorexia Nervosa
Start Date: Aug 26, 2019 - Last Update: October 26, 2021
Conditions: Anorexia Nervosa
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects
Start Date: Jul 04, 2019 - Last Update: December 1, 2020
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
Start Date: Apr 11, 2019 - Last Update: August 13, 2019
Conditions: Parkinson Disease Psychosis
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Concussion Headache
Start Date: Mar 28, 2019 - Last Update: July 28, 2022
Conditions: Post-Traumatic Headache
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin
Start Date: Mar 27, 2019 - Last Update: April 27, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept
Start Date: Mar 11, 2019 - Last Update: April 29, 2022
Conditions: Depressive Disorder, Major
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Start Date: Mar 01, 2019 - Last Update: January 26, 2022
Conditions: Treatment Resistant Depression
Location(s): United States, Canada, Czechia, Denmark, Germany, Ireland, Netherlands, Portugal, Spain, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Start Date: Jan 07, 2019 - Last Update: July 31, 2020
Conditions: Depressive Disorder, Major
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Treatment of Obsessive Compulsive Disorder
Start Date: Jan 02, 2019 - Last Update: July 15, 2022
Conditions: Obsessive-compulsive Disorder (OCD)
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Start Date: Nov 13, 2018 - Last Update: December 9, 2021
Conditions: Obsessive-Compulsive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin and Depression
Start Date: Sep 01, 2018 - Last Update: December 21, 2017
Conditions: Severe Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms
Start Date: Apr 09, 2018
Conditions: Major Depressive Disorder
Location(s): United Kingdom
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
Start Date: Feb 27, 2018 - Last Update: July 20, 2022
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Start Date: Jan 05, 2018 - Last Update: January 7, 2021
Conditions: Distress, Depression, Grief
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for the Treatment of Migraine Headache
Start Date: Nov 01, 2017 - Last Update: February 25, 2022
Conditions: Migraine Headache
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Major Depressive Disorder
Start Date: Aug 10, 2017 - Last Update: December 15, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Persisting Effects of Psilocybin
Start Date: Jul 01, 2017 - Last Update: September 10, 2019
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
Start Date: Jun 23, 2017 - Last Update: December 22, 2021
Conditions: Patients, Anxiety Disorders
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin as a tool for enhancing cognitive flexibility
Start Date: May 01, 2017 - Last Update:
Conditions: psilocybin, divergent thinking, neurotransmission
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: psilocybin
Study Title: The Neurobiological Effect of 5-HT2AR Modulation
Start Date: Mar 03, 2017 - Last Update: August 13, 2020
Conditions: Basic Science
Location(s): Denmark
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for the Treatment of Cluster Headache
Start Date: Nov 01, 2016 - Last Update: July 28, 2022
Conditions: Cluster Headache
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-facilitated Treatment for Cocaine Use
Start Date: May 01, 2015 - Last Update: August 2, 2022
Conditions: Cocaine-Related Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
Start Date: Apr 01, 2015 - Last Update: February 14, 2022
Conditions: Religious or Spiritual Problem
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
Start Date: Mar 01, 2015 - Last Update: June 2, 2022
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Assessing the subjective intensity of oral psilocybin in patients with treatment-resistant depression: A Pilot Study
Start Date: Jan 07, 2015
Conditions: Major depressive disorder
Location(s): United Kingdom
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI
Start Date: Jun 18, 2014
Conditions: Inclusion criteria:
Location(s): Czech Republic
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
Start Date: Jun 01, 2014 - Last Update: July 5, 2022
Conditions: Alcohol Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: UW Psilocybin Pharmacokinetics Study
Start Date: Jun 01, 2014 - Last Update: April 15, 2020
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Hallucinogens and Other Drugs on Mood and Performance
Start Date: Apr 01, 2014 - Last Update: May 16, 2019
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
Start Date: Oct 01, 2013 - Last Update: November 4, 2020
Conditions: Healthy
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Start Date: May 01, 2013 - Last Update: May 20, 2014
Conditions: Psilocybin, Hallucinogens, Pharmacologic Actions, Central Nervous System Agents, Therapeutic Uses, Psychotropic Drugs
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
Start Date: Jan 01, 2012 - Last Update: June 16, 2022
Conditions: Anxiety, Stage IV Melanoma
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
Start Date: Jan 01, 2012 - Last Update: February 10, 2014
Conditions: Alcohol Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin and Spiritual Practice
Start Date: Aug 01, 2009 - Last Update: February 24, 2016
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Cancer Anxiety Study
Start Date: Feb 01, 2009 - Last Update: October 20, 2020
Conditions: Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Start Date: Sep 01, 2008 - Last Update: October 4, 2021
Conditions: Nicotine Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psychopharmacology of Psilocybin in Cancer Patients
Start Date: Apr 01, 2007 - Last Update: July 19, 2018
Conditions: Depressive Symptoms, Anxiety, Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Start Date: Apr 01, 2004 - Last Update: April 22, 2022
Conditions: Anxiety
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The safety and efficacy of psilocybin as an adjunctive therapy in participants with treatment-resistant depression
Start Date:
Conditions: treatment resistant depression
Location(s): Ireland
Source: www.clinicaltrialsregister.eu
short summary



Total execution time in seconds: 0.023582935333252